New FDA Approval: MYDCOMBI
We have exciting news for patients at Compton Eye Associates: the FDA has recently approved MYDCOMBI™, a novel ophthalmic spray developed by Eyenovia, Inc. This approval marks a significant [...]
Interesting articles
Blog
Atropine for Children’s Myopia: A Guide for Parents
Myopia, or nearsightedness, is a prevalent and concerning condition among children. The treatment landscape has evolved over the years, with atropine eye drops emerging as a prominent option. [...]
Advanced Vision, Advanced Comfort: The U.S. Debut of INFUSE Multifocal SiHy Contacts
As we step into the summer of 2023, a groundbreaking advancement in eye care has made its way to the U.S.: Bausch + Lomb’s INFUSE Multifocal SiHy Contacts. At Compton Eye Associates, [...]
Why Do Eye Doctors Use Dilation Drops?
When you visit an eye doctor for a comprehensive eye exam, you may have experienced the use of dilation drops. But what are these drops, and why are they used? In this post, we’ll explore [...]